Cellular Postconditioning: Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate Microvascular Obstruction When Administered After Reperfusion in Pigs With Acute Myocardial Infarction

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation: Heart Failure

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.114.001484PMID 25587096PMCID PMC4366297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).

  2014cited by this paper
• Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart

  2013influential reference
• Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains.

  2013cited by this paper
• Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial Infarction

  2013cited by this paper
• Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function

  2013influential reference
• Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction

  2013cited by this paper
• Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.

  2012cited by this paper
• Magnetic Enhancement of Cell Retention, Engraftment, and Functional Benefit after Intracoronary Delivery of Cardiac-Derived Stem Cells in a Rat Model of Ischemia/Reperfusion

  2012cited by this paper
• Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.

  2012cited by this paper
• Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-Derived Cells

  2012cited by this paper
• Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study

  2011cited by this paper
• miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes

  2011cited by this paper
• Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

  2011cited by this paper
• Delayed Postconditioning in the Mouse Heart In Vivo

  2011cited by this paper
• Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice

  2010cited by this paper
• Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction

  2010cited by this paper
• Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy

  2009cited by this paper
• Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy.

  2009cited by this paper
• Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.

  2008cited by this paper
• Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction.

  2008cited by this paper
• Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention

  2008cited by this paper
• Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium

  2008cited by this paper
• Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

  2008cited by this paper
• Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.

  2008cited by this paper
• Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques

  2007cited by this paper
• Myocardial reperfusion injury.

  2007cited by this paper
• Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart

  2007cited by this paper
• Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement

  2006cited by this paper
• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  2006cited by this paper
• A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

  2006cited by this paper
• Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

  2006cited by this paper
• Quantitative Two-dimensional Echocardiographic Measurements Are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction The Protective Effects of Captopril

  2005cited by this paper
• The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.

  2005cited by this paper
• Quantitative Two-dimensional Echocardiographic Measurements Are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction The Protective Effects of Captopril

  2005cited by this paper
• Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

  2004cited by this paper
• Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion.

  2004cited by this paper
• Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

  2004cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003cited by this paper
• Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

  2003cited by this paper
• Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

  2003cited by this paper
• Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.

  2000cited by this paper
• Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.

  1999cited by this paper
• The role of neutrophils in myocardial ischemia-reperfusion injury.

  1999cited by this paper
• Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.

  1998cited by this paper
• Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.

  1998influential reference
• Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

  1998cited by this paper
• Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.

  1996cited by this paper
• TIMI frame count: a quantitative method of assessing coronary artery flow.

  1996cited by this paper
• Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

  1994cited by this paper
• Ventricular remodeling after myocardial infarction.

  1993cited by this paper
• Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications

  1990cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

  1981influential reference

• Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models

  2026cites this paper
• Cardiosphere-Derived Cells from Not Dilated and Dilated Human Myocardium Exhibit Enhanced Metabolic Potential Compared with Conventional Cardiac Mesenchymal Stem/Stromal Cells

  2026cites this paper
• Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon

  2025cites this paper
• Pretreatment with estrogen enhances the therapeutic efficacy of cardiac progenitor cells and improves cardiac recovery in a failing heart model

  2025cites this paper
• An overview on cardiac regeneration revolution: exploring the promise of stem cell therapies

  2025cites this paper
• Cardiac progenitor cell therapy: mechanisms of action

  2024cites this paper
• Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis

  2024cites this paper
• Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model

  2023cites this paper
• Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated

  2023cites this paper
• Engineered extracellular vesicles and their mimics in cardiovascular diseases.

  2022cites this paper
• Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis

  2022cites this paper
• Stem Cell-Based 3D Bioprinting for Cardiovascular Tissue Regeneration

  2022cites this paper
• Widespread Intracoronary Allogeneic Cardiosphere-Derived Cell Therapy With and Without Cyclosporine in Reperfused Myocardial Infarction.

  2022cites this paper
• Epicardial Delivery of Cardiosphere Derived Cells or Their Extracellular Vesicles in a Relevant Infarcted Swine Model: Safe, Easy but of Limited Effectiveness.

  2021cites this paper
• Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease

  2021cites this paper
• Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA

  2021cites this paper
• Stem Cells in Cardiovascular Diseases: 30,000-Foot View

  2021cites this paper
• Neutrophils aid cellular therapeutics by enhancing glycoengineered stem cell recruitment and retention at sites of inflammation.

  2021cites this paper
• The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

  2021cites this paper
• Benefits of cryopreservation as long-term storage method of encapsulated cardiosphere-derived cells for cardiac therapy: a biomechanical analysis.

  2021cites this paper
• Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling

  2020cites this paper
• Quantitative Hybrid Cardiac [18F]FDG-PET-MRI Images for Assessment of Cardiac Repair by Preconditioned Cardiosphere-Derived Cells

  2020cites this paper
• Cortical Bone Derived Stem Cells Modulate Cardiac Fibroblast Response via miR-18a in the Heart After Injury

  2020cites this paper
• Heart regeneration in mouse and human: A bioengineering perspective.

  2020cites this paper
• Heart-derived cells for therapeutics

  2020cites this paper
• Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.

  2020cites this paper
• Author Correction: The Intrapericardial Delivery of Extracellular Vesicles from Cardiosphere-Derived Cells Stimulates M2 Polarization during the Acute Phase of Porcine Myocardial Infarction

  2020cites this paper
• Role of Macrophages in Cardioprotection

  2019cites this paper
• New era of heart failure therapy in pediatrics: Cardiac stem cell therapy on the start line.

  2019cites this paper
• Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.

  2019cites this paper
• Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models

  2019cites this paper
• Role of cardiac progenitor cell‐derived exosome‐mediated microRNA‐210 in cardiovascular disease

  2019cites this paper
• The Intrapericardial Delivery of Extracellular Vesicles from Cardiosphere-Derived Cells Stimulates M2 Polarization during the Acute Phase of Porcine Myocardial Infarction

  2019cites this paper
• Macrophages in cardiac repair: Environmental cues and therapeutic strategies

  2019cites this paper
• Encapsulation of Explant-Derived Cardiac Stem Cells in Agarose Nanoporous Gel Cocoons to Enhance Cardiac Repair

  2019cites this paper
• Cell Therapy for Heart Disease: Ready for Prime Time or Lost in Translation?

  2019cites this paper
• Safety and efficacy of global intracoronary administration of cardiosphere-derived cells or conditioned medium immediately after coronary reperfusion in rats.

  2019cites this paper
• Non-occlusive Multi-Vessel Intracoronary Infusion of Allogeneic Cardiosphere-Derived Cells Prevents Remote Zone Myocyte Loss in Swine with Myocardial Infarction.

  2019cites this paper
• Human Embryonic Stem Cell-Derived Cardiovascular Progenitors Repair Infarcted Hearts Through Modulation of Macrophages via Activation of Signal Transducer and Activator of Transcription 6

  2019cites this paper
• Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells

  2019cites this paper
• Angina and Ischemia in Women with No Obstructive Coronary Artery Disease

  2018cites this paper
• Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

  2018cites this paper
• Gender Differences in the Pathogenesis and Management of Heart Disease

  2018cites this paper
• Post-infarct cardiac injury, protection and repair: roles of non-cardiomyocyte multicellular and acellular components

  2018cites this paper
• Preclinical Studies of Stem Cell Therapy for Heart Disease

  2018cites this paper
• Does a Newly Characterized Cell From the Bone Marrow Repair the Heart After Acute Myocardial Infarction?

  2018cites this paper
• Cardiosphere-Derived Cells and Ischemic Heart Failure.

  2018cites this paper
• Regenerative Therapy for Cardiomyopathies

  2018cites this paper
• Cardiovascular Magnetic Resonance in Acute ST-Segment–Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions

  2018cites this paper
• Regenerative medicine therapy for single ventricle congenital heart disease.

  2018cites this paper
• Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases

  2018cites this paper
• Targeted repair of heart injury by stem cells fused with platelet nanovesicles

  2018cites this paper
• Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects

  2018cites this paper
• New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.

  2018cites this paper
• Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions

  2018cites this paper
• Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis

  2018cites this paper
• The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy

  2018cites this paper
• Stem cell-derived exosomes - an emerging tool for myocardial regeneration

  2018cites this paper
• 25 – Angina in Patients with Evidence of Myocardial Ischemia and No Obstructive Coronary Artery Disease

  2018cites this paper
• CPCs and ECM: A Good Mix for Cardiac Regeneration

  2018cites this paper
• Is Cardioprotection Dead?

  2017cites this paper
• New Strategies for Myocardial Infarction Treatment

  2017cites this paper
• Stem Cell Therapy for Ischemic Heart Disease

  2017cites this paper
• Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning

  2017cites this paper
• Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types

  2017cites this paper
• Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia.

  2017cites this paper
• Myocardial fibrosis: biomedical research from bench to bedside

  2017cites this paper
• Cryoinjury-induced acute myocardial infarction model and ameroid constrictor-induced ischemic heart disease model in adult micro-mini pigs for preclinical studies

  2017cites this paper
• Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL‐10 expression and secretion

  2017cites this paper
• Intracoronary allogeneic cardiosphere‐derived stem cells are safe for use in dogs with dilated cardiomyopathy

  2017cites this paper
• Exosomes and cardioprotection – A critical analysis

  2017cites this paper
• Roles of exosomes in cardioprotection.

  2016cites this paper
• The effects of transplanted cells in stem cell therapy for myocardial ischemia

  2016cites this paper
• Widespread Intracoronary Cardiopoietic Cell Infusion: Treating at the Time of Myocardial Reperfusion to Prevent Rather Than Reverse Established Left Ventricular Dysfunction Moves Us Closer to Practical Clinical Translation.

  2016cites this paper
• Bringing cardiac stem cell therapy from bench to bedside: lessons from the past and future perspectives.

  2016cites this paper
• Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells

  2016cites this paper
• Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro

  2016cites this paper
• Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies.

  2016cites this paper
• Durable Benefits of Cellular Postconditioning: Long‐Term Effects of Allogeneic Cardiosphere‐Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction

  2016cites this paper
• Allogeneic cardiosphere-derived cells for myocardial regeneration: current progress and recent results.

  2016cites this paper
• Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction

  2016cites this paper
• Cardiac Stem Cell Treatment in Myocardial InfarctionNovelty and Significance

  2016cites this paper
• Manifestations of Myocardial Ischemia / Reperfusion Injury in the Coronary Circulation

  2016cites this paper
• The Coronary Circulation as a Target of Cardioprotection.

  2016cites this paper
• Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone?

  2015cites this paper
• Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction.

  2015cites this paper
• Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial

  2015cites this paper
• Models for preclinical studies in aging-related disorders: One is not for all

  2015cites this paper
• Translational research of adult stem cell therapy.

  2015cites this paper